| Schedule of Segment Information |
The
following table is a summary of segment information for three months ended March 31, 2026 and 2025 (amounts in thousands):
Schedule
of Segment Information
| | |
March
31, 2026 | | |
March
31, 2025 | |
| | |
For
the three months ended | |
| | |
March
31, 2026 | | |
March
31, 2025 | |
| Net revenues | |
| | | |
| | |
| Diagnostic services | |
$ | - | | |
$ | - | |
| Consumer
products | |
| 478 | | |
| 1,431 | |
| Consolidated net revenue | |
| 478 | | |
| 1,431 | |
| Cost of revenue | |
| | | |
| | |
| Diagnostic services | |
| - | | |
| 232 | |
| Consumer
products | |
| 311 | | |
| 673 | |
| Consolidated cost of revenue | |
| 311 | | |
| 905 | |
| Depreciation and amortization
expense | |
| | | |
| | |
| Diagnostic services | |
| - | | |
| 334 | |
| Consumer
products | |
| 623 | | |
| 807 | |
| Total Depreciation and
amortization expense | |
| 623 | | |
| 1,141 | |
| Operating and other expenses | |
| | | |
| | |
| Diagnostic services | |
| - | | |
| 168 | |
| Consumer products | |
| 562 | | |
| 1,061 | |
| Unallocated
corporate | |
| 2,962 | | |
| 2,834 | |
| Total operating and other
expenses | |
| 3,524 | | |
| 4,063 | |
| Income (loss) from operations,
before income taxes | |
| | | |
| | |
| Income
tax expense | |
| (1,374 | ) | |
| - | |
| Total
loss from operations, after income taxes | |
| (5,354 | ) | |
| (4,678 | ) |
| Net
loss from continuing operations | |
$ | (5,354 | ) | |
$ | (4,678 | ) |
The
following table is a summary of segment information as of March 31, 2026 and December 31, 2025 (amounts in thousands):
| | |
March
31, 2026 | | |
December
31, 2025 | |
| ASSETS | |
| | | |
| | |
| Consumer products | |
$ | 10,973 | | |
$ | 11,614 | |
| Unallocated corporate | |
| 47,757 | | |
| 48,257 | |
| Total assets | |
$ | 58,730 | | |
$ | 59,871 | |
|